US' Largest AIDS Group Calls for Funding Suspension After Trial Failures
WASHINGTON, March 23 /PRNewswire-USNewswire/ -- In a Baltimore Sun opinion piece today (http://www.baltimoresun.com/news/opinion/oped/bal- op.aidsvaccine23mar23,0,3426636.story), AIDS Healthcare Foundation (AHF) called for the suspension of costly HIV vaccine research funding and the re- allocation of resources into effective, proven HIV/AIDS prevention, testing and treatment strategies.
Co-authored by Dr. Homayoon Khanlou, AHF's Chief of Medicine/U.S. and Michael Weinstein, AHF's President, the op ed, "Enough is Enough," has been published on the eve of the HIV Vaccine Summit assembled by the director of the National Institute of Allergy and Infectious Diseases (NIAID) Dr. Anthony Fauci and scheduled for this upcoming Tuesday, March 25th in Bethesda, Maryland. This meeting of top leaders in the field is being convened at the urging of members of the scientific community concerned by the overall HIV vaccine funding strategy in the wake of a string of recent, highly publicized trial failures. The text of AHF's opinion editorial is below:
Enough is Enough
Instead of continuing to squander hundreds of millions of dollars on a futile quest for an HIV vaccine, focus AIDS spending on prevention, testing and treatment
By Homayoon Khanlou and Michael Weinstein
To control AIDS, funding must be invested in strategies that work: effective prevention efforts, routine testing and universal access to treatment - and not spent on expensive vaccine research that over 20 years has yielded little of promise other than discovering how not to make an AIDS vaccine.
The latest round of vaccine trial failures (including a large-scale
Merck trial halted when the vaccine turned out to have possibly increased
subjects' risk of acquiring HIV) has added to a growing consensus in the
scientifi
'/>"/>
| SOURCE AIDS Healthcare Foundation Copyright©2008 PR Newswire. All rights reserved |